๐Ÿฉบ OPIOIDS ๐Ÿท๏ธ Analgesic/Narcotic analgesic
๐Ÿ‘จโ€โš•๏ธ Clinically Reviewed by: PakistaniBano Medical Editorial Board (Pharm.D Panel)
๐Ÿ“… Reviewed: November 2026 โ€ข ๐Ÿ” Authority: DRAP / WHO ATC
๐Ÿ“ฆ Formulations, Pack Sizes & Retail Prices Currency: Rs.
Dosage Form Reg. No Pack Size Trade Price (TP) Maximum Retail Price (MRP)
Inj 10mg 95224 1ml x 10 Rs.753.45 Rs.886.41
Inj 20mg 95225 1ml x 10 Rs.965.52 Rs.1135.90
Tab 75mg 74501 2x10 Rs.142.49 Rs.167.64

๐Ÿ“‹ Indications & Clinical Dosage

*Moderate to severe pain, Pre-and post-operative analgesia:* BY IV, IM OR SC INJ: Adults: 10-20 mg. *Pain in suspected myocardial infarction:* BY SLOW IV INJ: Adults: 10-30 mg A repeat dose of 20 mg may be given within 30 min, if necessary. Children: Not recommended.

โ›” Contraindications

Acute respiratory depression, comatose patients, head injury and raised intracranial pressure (opioid analgesics interfere with pupillary responses vital for neurological assessment), risk of paralytic ileus

โš ๏ธ Precautions & Warnings

Renal or hepatic impairment, adrenocortical insufficiency and hypothyroidism (reduced dose), asthma (avoid during an acute attack), convulsive disorders, diseases of the biliary tract, hypotension, elderly and debilitated patients (reduced dose), impaired respiratory function (avoid in chronic obstructive pulmonary disease), inflammatory bowel disorders, myasthenia gravis, obstructive bowel disorders, prostatic hypertrophy, shock, urethral stenosis, history of opioid abuse.

๐Ÿ”„ Drug Interactions

CNS depressants.

โš ๏ธ Adverse Reactions / Side Effects

Biliary spasm, bradycardia, confusion, constipation, dependence, difficulty with micturition, dizziness, drowsiness, dry mouth, dysphoria, euphoria, flushing, hallucinations, headache, hypotension and muscle rigidity (larger doses), miosis, nausea, oedema, palpitation, postural hypotension, pruritus, rash, respiratory depression (larger doses), sexual dysfunction, sleep disturbances, sweating, tachycardia, ureteric spasm, urinary retention, urticaria, vertigo, visual disturbances, vomiting, Adrenal insufficiency and hyperalgesia (long-term use), hypogonadism (long-termuse)

๐Ÿคฐ Pregnancy & Lactation Safety

Pregnancy Risk:
Positive evidence of risk: Respiratory depression and withdrawal symptoms in the neonate; gastric stasis and inhalation pneumonia in the mother if opioid analgesics are used during labour and
Lactation / Breastfeeding:
Caution advised

๐Ÿงช Compatibility & Storage Stability

Compatibility: Dextrose 5% in NaCI 0.9%, Dextrose 5%, 0.9% NaCI, LR, incompatible with diazepam or pentobarbi-tal. Use separate IV line or flush line well before and after administration.

Stability & Storage: Stable for 48 hours when diluted in 1:1 and 1:2 ratios with diluents.

๐Ÿ“š Official Regulatory & Clinical References

  • Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
  • World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
  • Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.

Related Medicines

Medicines related to this brand, grouped by relevance.

Same generic: NALBUPHINE

AKNAL
AKHAI
Rs.513.87
ANALIN
MEDICAIDS
Rs.999 .00
ASTIKAY
ASTELLAS
Rs.437.00
Rs.1660.00
BUNAIL
BOSCH
Rs.400.00
BUPHAIN
MACTER
Rs.1055.00

More from CALIPH

A-ZATRO
CALIPH
Rs.284.18
ADESTA
CALIPH
Rs.318.22
AVOLIDS
CALIPH
Rs.150.93

Same category: OPIOIDS

ACETRA
AMARANT
Rs.115.00
ASTADOL
ASTA RL
Rs.190.00
BENORINE
BROOKES
Rs.372.71

โšก Quick Actions

๐Ÿ’ฌ Share via WhatsApp